An experimental HIV drug that has been used to successfully treat COVID-19 patients is in its second phase of testing with the Food and Drug Administration and could potentially be approved for use in four weeks, its manufacturer says. Leronlimab, made by the biotech company CytoDyn, was used to treat a handful of severely ill […]